Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solix Algredients, originally founded as Solix Biofuels, is a biotechnology company that specializes in the cultivation of microalgae for high-value natural ingredients. The company transitioned from its initial focus on algal biofuels to the nutraceutical and functional food markets, leveraging its proprietary Algal Growth System (AGS) technology. This closed-system photobioreactor platform allows for the controlled production of high-purity algal biomass, which is processed into products like Solasta astaxanthin and Solmega docosahexaenoic acid. In 2019, the company was acquired by BGG World, a global leader in natural botanical ingredients, to serve as their primary algal production and innovation hub. The integration allowed BGG to expand its portfolio of sustainably produced, algae-based health products for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solix Biofuels.